Clinical and biological characteristics of MGUS and SMM patients... | Download Table
What is the significance of monoclonal gammopathy of undetermined significance? | RCP Journals
Screening for Monoclonal Gammopathy of Undetermined Significance: First Results from the iStopMM Study
Demographic and clinical data (mean values) for patients with MGUS and... | Download Table
New IMWG Criteria Reflect Change in Practice - Clinical Oncology News
Table 2 from Monoclonal gammopathy of undetermined significance. | Semantic Scholar
2 Batten Disease Clinical Trials Enrolling Patients to Test Gene Therapies
Vincent Rajkumar on Twitter: "Here is the management approach to MGUS. Uncomplicated patients with low risk MGUS do not need a baseline bone marrow or bone survey, and don't need annual follow
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies | Blood Cancer Journal
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to management - Maciocia - 2017 - Hematological Oncology - Wiley Online Library
Future Directions in the Evaluation and Treatment of Precursor Plasma Cell Disorders | American Society of Clinical Oncology Educational Book
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies | Blood Cancer Journal
Treatment of Smoldering Myeloma Delays Disease Progression, Yet Questions Remain
CRO Perspectives: Driving Innovation, Consistency and Reliability in Multiple Myeloma Clinical Trials - Insights From Our Labs to Yours
Vincent Rajkumar on Twitter: "Note that 90% of patients with MGUS will never get myeloma or related disorder. @NEJM @MayoClinic https://t.co/Ko6EUZOKnD" / Twitter
Meeting Library | Psychosocial effects of the relaxation response resiliency program (SMART-3RP) in patients with MGUS and smoldering multiple myeloma: A waitlist controlled randomized clinical trial.
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to management - Maciocia - 2017 - Hematological Oncology - Wiley Online Library
Multiple Myeloma Clinical Trials
MC Community Event: Clinical Trials for High Risk Smoldering Myeloma Patients
CONSORT flowchart for A single-arm, open-label, phase 2 clinical trial... | Download Scientific Diagram
INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myeloma | Future Oncology
Multiple myeloma - The Lancet
Multiple myeloma | Nature Reviews Disease Primers
MGUS Clinical Trials
PLOS Medicine: Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
Clinical trials of bisphosphonates in multiple myeloma. | Semantic Scholar
What Are MGUS, Smoldering and Active Myeloma? | The IMF
Treatment Strategies for Patients with Multiple Myeloma: from Clinical Trials to Real Life | Frontiers Research Topic
